메뉴 건너뛰기




Volumn , Issue , 2016, Pages 179-197

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics

Author keywords

Alzheimer s disease; chelation therapy; iron; metals; neurodegeneration; Parkinson s disease

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYTOCHROME B; DEFERIPRONE; FERRITIN; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON; IRON REGULATORY FACTOR; MESSENGER RNA; PROTON COUPLED FOLATE TRANSPORTER; REACTIVE OXYGEN METABOLITE;

EID: 85028253570     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13425     Document Type: Review
Times cited : (446)

References (232)
  • 1
    • 20244372858 scopus 로고    scopus 로고
    • Hemochromatosis and iron-overload screening in a racially diverse population
    • Adams P. C., Reboussin D. M., Barton J. C. et al. (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med. 352, 1769–1778.
    • (2005) N. Engl. J. Med. , vol.352 , pp. 1769-1778
    • Adams, P.C.1    Reboussin, D.M.2    Barton, J.C.3
  • 2
    • 46149107512 scopus 로고    scopus 로고
    • Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta
    • Adlard P. A., Cherny R. A., Finkelstein D. I. et al. (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43–55.
    • (2008) Neuron , vol.59 , pp. 43-55
    • Adlard, P.A.1    Cherny, R.A.2    Finkelstein, D.I.3
  • 3
    • 79952610782 scopus 로고    scopus 로고
    • Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease
    • Adlard P. A., Bica L., White A. R. et al. (2011) Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease. PLoS ONE, 6, e17669.
    • (2011) PLoS ONE , vol.6
    • Adlard, P.A.1    Bica, L.2    White, A.R.3
  • 4
    • 0036670712 scopus 로고    scopus 로고
    • Aggregation and neurotoxicity of alpha-synuclein and related peptides
    • el-Agnaf O. M. and Irvine G. B. (2002) Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem. Soc. Trans. 30, 559–565.
    • (2002) Biochem. Soc. Trans. , vol.30 , pp. 559-565
    • el-Agnaf, O.M.1    Irvine, G.B.2
  • 5
    • 84903368557 scopus 로고    scopus 로고
    • H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment
    • Ali-Rahmani F., Grigson P. S., Lee S., Neely E., Connor J. R. and Schengrund C. L. (2014) H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment. Neurobiol. Aging 35, 1511, e1511–1512.
    • (2014) Neurobiol. Aging , vol.35 , pp. 1511-1512
    • Ali-Rahmani, F.1    Grigson, P.S.2    Lee, S.3    Neely, E.4    Connor, J.R.5    Schengrund, C.L.6
  • 6
    • 43249100611 scopus 로고    scopus 로고
    • Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
    • Amit T., Avramovich-Tirosh Y., Youdim M. B. and Mandel S. (2008) Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. FASEB J. 22, 1296–1305.
    • (2008) FASEB J. , vol.22 , pp. 1296-1305
    • Amit, T.1    Avramovich-Tirosh, Y.2    Youdim, M.B.3    Mandel, S.4
  • 8
    • 84864319642 scopus 로고    scopus 로고
    • Mammalian iron metabolism and its control by iron regulatory proteins
    • Anderson C. P., Shen M., Eisenstein R. S. and Leibold E. A. (2012) Mammalian iron metabolism and its control by iron regulatory proteins. Biochim. Biophys. Acta 1823, 1468–1483.
    • (2012) Biochim. Biophys. Acta , vol.1823 , pp. 1468-1483
    • Anderson, C.P.1    Shen, M.2    Eisenstein, R.S.3    Leibold, E.A.4
  • 9
    • 77953810574 scopus 로고    scopus 로고
    • Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage
    • Arosio P. and Levi S. (2010) Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim. Biophys. Acta 1800, 783–792.
    • (2010) Biochim. Biophys. Acta , vol.1800 , pp. 783-792
    • Arosio, P.1    Levi, S.2
  • 10
    • 67349100157 scopus 로고    scopus 로고
    • Ferritins: a family of molecules for iron storage, antioxidation and more
    • Arosio P., Ingrassia R. and Cavadini P. (2009) Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim. Biophys. Acta 1790, 589–599.
    • (2009) Biochim. Biophys. Acta , vol.1790 , pp. 589-599
    • Arosio, P.1    Ingrassia, R.2    Cavadini, P.3
  • 11
    • 7244242355 scopus 로고    scopus 로고
    • T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores
    • Atasoy H. T., Nuyan O., Tunc T., Yorubulut M., Unal A. E. and Inan L. E. (2004) T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol. India 52, 332–337.
    • (2004) Neurol. India , vol.52 , pp. 332-337
    • Atasoy, H.T.1    Nuyan, O.2    Tunc, T.3    Yorubulut, M.4    Unal, A.E.5    Inan, L.E.6
  • 13
    • 84903870684 scopus 로고    scopus 로고
    • Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease
    • Ayton S., Lei P., Adlard P. A., Volitakis I., Cherny R. A., Bush A. I. and Finkelstein D. I. (2014) Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease. Mol. Neurodegener. 9, 27.
    • (2014) Mol. Neurodegener. , vol.9 , pp. 27
    • Ayton, S.1    Lei, P.2    Adlard, P.A.3    Volitakis, I.4    Cherny, R.A.5    Bush, A.I.6    Finkelstein, D.I.7
  • 14
    • 84930225631 scopus 로고    scopus 로고
    • Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE
    • Ayton S., Faux N. G. and Bush A. I. and Alzheimer's Disease Neuroimaging, I. (2015a) Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat. Commun. 6, 6760.
    • (2015) Nat. Commun. , vol.6 , pp. 6760
    • Ayton, S.1    Faux, N.G.2    Bush, A.I.3
  • 15
    • 84926617255 scopus 로고    scopus 로고
    • Biometals and their therapeutic implications in Alzheimer's disease
    • Ayton S., Lei P. and Bush A. I. (2015b) Biometals and their therapeutic implications in Alzheimer's disease. Neurotherapeutics 12, 109–120.
    • (2015) Neurotherapeutics , vol.12 , pp. 109-120
    • Ayton, S.1    Lei, P.2    Bush, A.I.3
  • 16
    • 84923347844 scopus 로고    scopus 로고
    • Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein
    • Ayton S., Lei P., Hare D. J. et al. (2015c) Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein. J. Neurosci. 35, 3591–3597.
    • (2015) J. Neurosci. , vol.35 , pp. 3591-3597
    • Ayton, S.1    Lei, P.2    Hare, D.J.3
  • 18
    • 0005652488 scopus 로고    scopus 로고
    • MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease
    • Bartzokis G. and Tishler T. A. (2000) MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell. Mol. Biol. 46, 821–833.
    • (2000) Cell. Mol. Biol. , vol.46 , pp. 821-833
    • Bartzokis, G.1    Tishler, T.A.2
  • 20
    • 34548790267 scopus 로고    scopus 로고
    • Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications
    • Bartzokis G., Lu P. H., Tishler T. A. et al. (2007) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem. Res. 32, 1655–1664.
    • (2007) Neurochem. Res. , vol.32 , pp. 1655-1664
    • Bartzokis, G.1    Lu, P.H.2    Tishler, T.A.3
  • 21
    • 0018894715 scopus 로고
    • A non-transferrin-bound serum iron in idiopathic hemochromatosis
    • Batey R. G., Lai Chung Fong P., Shamir S. and Sherlock S. (1980) A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig. Dis. Sci. 25, 340–346.
    • (1980) Dig. Dis. Sci. , vol.25 , pp. 340-346
    • Batey, R.G.1    Lai Chung Fong, P.2    Shamir, S.3    Sherlock, S.4
  • 22
    • 0035153971 scopus 로고    scopus 로고
    • Iron biology in immune function, muscle metabolism and neuronal functioning
    • discussion 580S
    • Beard J. L. (2001) Iron biology in immune function, muscle metabolism and neuronal functioning. J. Nutr. 131, 568S–579S; discussion 580S.
    • (2001) J. Nutr. , vol.131 , pp. 568S-579S
    • Beard, J.L.1
  • 23
    • 12244310166 scopus 로고    scopus 로고
    • Brain iron uptake in hypotransferrinemic mice: influence of systemic iron status
    • Beard J. L., Wiesinger J. A., Li N. and Connor J. R. (2005) Brain iron uptake in hypotransferrinemic mice: influence of systemic iron status. J. Neurosci. Res. 79, 254–261.
    • (2005) J. Neurosci. Res. , vol.79 , pp. 254-261
    • Beard, J.L.1    Wiesinger, J.A.2    Li, N.3    Connor, J.R.4
  • 24
    • 34247564692 scopus 로고    scopus 로고
    • Role of iron in neurodegenerative disorders
    • Berg D. and Youdim M. B. (2006) Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 17, 5–17.
    • (2006) Top. Magn. Reson. Imaging , vol.17 , pp. 5-17
    • Berg, D.1    Youdim, M.B.2
  • 25
    • 0033595447 scopus 로고    scopus 로고
    • Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
    • Berg D., Becker G., Zeiler B. et al. (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53, 1026–1031.
    • (1999) Neurology , vol.53 , pp. 1026-1031
    • Berg, D.1    Becker, G.2    Zeiler, B.3
  • 26
    • 84857977037 scopus 로고    scopus 로고
    • Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms
    • von Bernhardi R. and Eugenin J. (2012) Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid. Redox Signal. 16, 974–1031.
    • (2012) Antioxid. Redox Signal. , vol.16 , pp. 974-1031
    • von Bernhardi, R.1    Eugenin, J.2
  • 27
    • 0035126635 scopus 로고    scopus 로고
    • Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis
    • Bidmon H. J., Emde B., Oermann E., Kubitz R., Witte O. W. and Zilles K. (2001) Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis. Exp. Neurol. 168, 1–22.
    • (2001) Exp. Neurol. , vol.168 , pp. 1-22
    • Bidmon, H.J.1    Emde, B.2    Oermann, E.3    Kubitz, R.4    Witte, O.W.5    Zilles, K.6
  • 28
    • 84855461629 scopus 로고    scopus 로고
    • MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
    • Bilgic B., Pfefferbaum A., Rohlfing T., Sullivan E. V. and Adalsteinsson E. (2012) MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. NeuroImage 59, 2625–2635.
    • (2012) NeuroImage , vol.59 , pp. 2625-2635
    • Bilgic, B.1    Pfefferbaum, A.2    Rohlfing, T.3    Sullivan, E.V.4    Adalsteinsson, E.5
  • 29
    • 34347370842 scopus 로고    scopus 로고
    • Selective iron chelation in Friedreich ataxia: biologic and clinical implications
    • Boddaert N., Le Quan Sang K. H., Rotig A. et al. (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110, 401–408.
    • (2007) Blood , vol.110 , pp. 401-408
    • Boddaert, N.1    Le Quan Sang, K.H.2    Rotig, A.3
  • 30
    • 0028873173 scopus 로고
    • Iron levels modulate alpha-secretase cleavage of amyloid precursor protein
    • Bodovitz S., Falduto M. T., Frail D. E. and Klein W. L. (1995) Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J. Neurochem. 64, 307–315.
    • (1995) J. Neurochem. , vol.64 , pp. 307-315
    • Bodovitz, S.1    Falduto, M.T.2    Frail, D.E.3    Klein, W.L.4
  • 31
    • 0033597299 scopus 로고    scopus 로고
    • Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease
    • Boll M. C., Sotelo J., Otero E., Alcaraz-Zubeldia M. and Rios C. (1999) Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease. Neurosci. Lett. 265, 155–158.
    • (1999) Neurosci. Lett. , vol.265 , pp. 155-158
    • Boll, M.C.1    Sotelo, J.2    Otero, E.3    Alcaraz-Zubeldia, M.4    Rios, C.5
  • 32
    • 0037428241 scopus 로고    scopus 로고
    • Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
    • Bonifati V., Rizzu P., van Baren M. J. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259.
    • (2003) Science , vol.299 , pp. 256-259
    • Bonifati, V.1    Rizzu, P.2    van Baren, M.J.3
  • 33
    • 0030739637 scopus 로고    scopus 로고
    • Transport of iron in the blood-brain-cerebrospinal fluid system
    • Bradbury M. W. (1997) Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69, 443–454.
    • (1997) J. Neurochem. , vol.69 , pp. 443-454
    • Bradbury, M.W.1
  • 34
    • 0033677772 scopus 로고    scopus 로고
    • The importance of non-transferrin bound iron in disorders of iron metabolism
    • Breuer W., Hershko C. and Cabantchik Z. I. (2000) The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus. Sci. 23, 185–192.
    • (2000) Transfus. Sci. , vol.23 , pp. 185-192
    • Breuer, W.1    Hershko, C.2    Cabantchik, Z.I.3
  • 35
    • 0035254193 scopus 로고    scopus 로고
    • Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy
    • Breuer W., Ermers M. J., Pootrakul P., Abramov A., Hershko C. and Cabantchik Z. I. (2001) Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 97, 792–798.
    • (2001) Blood , vol.97 , pp. 792-798
    • Breuer, W.1    Ermers, M.J.2    Pootrakul, P.3    Abramov, A.4    Hershko, C.5    Cabantchik, Z.I.6
  • 37
  • 38
    • 0022345593 scopus 로고
    • Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states
    • Brissot P., Wright T. L., Ma W. L. and Weisiger R. A. (1985) Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J. Clin. Invest. 76, 1463–1470.
    • (1985) J. Clin. Invest. , vol.76 , pp. 1463-1470
    • Brissot, P.1    Wright, T.L.2    Ma, W.L.3    Weisiger, R.A.4
  • 39
    • 84857373097 scopus 로고    scopus 로고
    • Non-transferrin bound iron: a key role in iron overload and iron toxicity
    • Brissot P., Ropert M., Le Lan C. and Loreal O. (2012) Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim. Biophys. Acta 1820, 403–410.
    • (2012) Biochim. Biophys. Acta , vol.1820 , pp. 403-410
    • Brissot, P.1    Ropert, M.2    Le Lan, C.3    Loreal, O.4
  • 42
    • 0037386086 scopus 로고    scopus 로고
    • The metallobiology of Alzheimer's disease
    • Bush A. I. (2003) The metallobiology of Alzheimer's disease. Trends Neurosci. 26, 207–214.
    • (2003) Trends Neurosci. , vol.26 , pp. 207-214
    • Bush, A.I.1
  • 43
    • 54249103057 scopus 로고    scopus 로고
    • Drug development based on the metals hypothesis of Alzheimer's disease
    • Bush A. I. (2008) Drug development based on the metals hypothesis of Alzheimer's disease. J. Alzheimers Dis. 15, 223–240.
    • (2008) J. Alzheimers Dis. , vol.15 , pp. 223-240
    • Bush, A.I.1
  • 44
    • 39749188801 scopus 로고    scopus 로고
    • Twenty years of metallo-neurobiology: where to now?
    • Bush A. I. and Curtain C. C. (2008) Twenty years of metallo-neurobiology: where to now? Eur. Biophys. J. 37, 241–245.
    • (2008) Eur. Biophys. J. , vol.37 , pp. 241-245
    • Bush, A.I.1    Curtain, C.C.2
  • 45
    • 84897930584 scopus 로고    scopus 로고
    • Labile iron in cells and body fluids: physiology, pathology, and pharmacology
    • Cabantchik Z. I. (2014) Labile iron in cells and body fluids: physiology, pathology, and pharmacology. Front. Pharmacol. 5, 45.
    • (2014) Front. Pharmacol. , vol.5 , pp. 45
    • Cabantchik, Z.I.1
  • 46
    • 38449094356 scopus 로고    scopus 로고
    • Iron-regulatory proteins: molecular biology and pathophysiological implications
    • Cairo G. and Recalcati S. (2007) Iron-regulatory proteins: molecular biology and pathophysiological implications. Expert Rev. Mol. Med. 9, 1–13.
    • (2007) Expert Rev. Mol. Med. , vol.9 , pp. 1-13
    • Cairo, G.1    Recalcati, S.2
  • 47
    • 84879845983 scopus 로고    scopus 로고
    • Roles of the amyloid precursor protein family in the peripheral nervous system
    • Caldwell J. H., Klevanski M., Saar M. and Muller U. C. (2013) Roles of the amyloid precursor protein family in the peripheral nervous system. Mech. Dev. 130, 433–446.
    • (2013) Mech. Dev. , vol.130 , pp. 433-446
    • Caldwell, J.H.1    Klevanski, M.2    Saar, M.3    Muller, U.C.4
  • 48
    • 84899898647 scopus 로고    scopus 로고
    • Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging
    • Callaghan M. F., Freund P., Draganski B. et al. (2014) Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging. Neurobiol. Aging 35, 1862–1872.
    • (2014) Neurobiol. Aging , vol.35 , pp. 1862-1872
    • Callaghan, M.F.1    Freund, P.2    Draganski, B.3
  • 49
    • 0242500486 scopus 로고    scopus 로고
    • Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy
    • Candore G., Licastro F., Chiappelli M. et al. (2003) Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy. Mech. Ageing Dev. 124, 525–528.
    • (2003) Mech. Ageing Dev. , vol.124 , pp. 525-528
    • Candore, G.1    Licastro, F.2    Chiappelli, M.3
  • 50
  • 51
    • 33747429095 scopus 로고    scopus 로고
    • Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency
    • Chan A. and Shea T. B. (2006) Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. J. Alzheimers Dis. 9, 399–405.
    • (2006) J. Alzheimers Dis. , vol.9 , pp. 399-405
    • Chan, A.1    Shea, T.B.2
  • 52
    • 0035911810 scopus 로고    scopus 로고
    • Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains
    • Cheepsunthorn P., Palmer C., Menzies S., Roberts R. L. and Connor J. R. (2001) Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains. J. Comp. Neurol. 431, 382–396.
    • (2001) J. Comp. Neurol. , vol.431 , pp. 382-396
    • Cheepsunthorn, P.1    Palmer, C.2    Menzies, S.3    Roberts, R.L.4    Connor, J.R.5
  • 53
    • 84885404060 scopus 로고    scopus 로고
    • Iron Accumulates in Huntington's Disease Neurons: protection by Deferoxamine
    • Chen J. F., Marks E., Lai B. et al. (2013) Iron Accumulates in Huntington's Disease Neurons: protection by Deferoxamine. PLoS ONE, 8, e77023.
    • (2013) PLoS ONE , vol.8
    • Chen, J.F.1    Marks, E.2    Lai, B.3
  • 54
    • 0034964390 scopus 로고    scopus 로고
    • Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
    • Cherny R. A., Atwood C. S., Xilinas M. E. et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665–676.
    • (2001) Neuron , vol.30 , pp. 665-676
    • Cherny, R.A.1    Atwood, C.S.2    Xilinas, M.E.3
  • 55
    • 84885372632 scopus 로고    scopus 로고
    • PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease
    • Cherny R. A., Ayton S., Finkelstein D. I., Bush A. I., McColl G. and Massa S. M. (2012) PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease. J. Huntingtons Dis. 1, 211–219.
    • (2012) J. Huntingtons Dis. , vol.1 , pp. 211-219
    • Cherny, R.A.1    Ayton, S.2    Finkelstein, D.I.3    Bush, A.I.4    McColl, G.5    Massa, S.M.6
  • 57
    • 12244274984 scopus 로고    scopus 로고
    • Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease
    • Combarros O., Garcia-Roman M., Fontalba A., Fernandez-Luna J. L., Llorca J., Infante J. and Berciano J. (2003) Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 15, 151–154.
    • (2003) Dement. Geriatr. Cogn. Disord. , vol.15 , pp. 151-154
    • Combarros, O.1    Garcia-Roman, M.2    Fontalba, A.3    Fernandez-Luna, J.L.4    Llorca, J.5    Infante, J.6    Berciano, J.7
  • 58
    • 0030174825 scopus 로고    scopus 로고
    • Relationship of iron to oligodendrocytes and myelination
    • Connor J. R. and Menzies S. L. (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17, 83–93.
    • (1996) Glia , vol.17 , pp. 83-93
    • Connor, J.R.1    Menzies, S.L.2
  • 59
    • 0025648166 scopus 로고
    • Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
    • Connor J. R., Menzies S. L., St Martin S. M. and Mufson E. J. (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27, 595–611.
    • (1990) J. Neurosci. Res. , vol.27 , pp. 595-611
    • Connor, J.R.1    Menzies, S.L.2    St Martin, S.M.3    Mufson, E.J.4
  • 60
    • 0026513756 scopus 로고
    • A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
    • Connor J. R., Menzies S. L., St Martin S. M. and Mufson E. J. (1992a) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75–83.
    • (1992) J. Neurosci. Res. , vol.31 , pp. 75-83
    • Connor, J.R.1    Menzies, S.L.2    St Martin, S.M.3    Mufson, E.J.4
  • 61
    • 0026590705 scopus 로고
    • Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease
    • Connor J. R., Snyder B. S., Beard J. L., Fine R. E. and Mufson E. J. (1992b) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31, 327–335.
    • (1992) J. Neurosci. Res. , vol.31 , pp. 327-335
    • Connor, J.R.1    Snyder, B.S.2    Beard, J.L.3    Fine, R.E.4    Mufson, E.J.5
  • 62
    • 0028350924 scopus 로고
    • Isoforms of ferritin have a specific cellular distribution in the brain
    • Connor J. R., Boeshore K. L., Benkovic S. A. and Menzies S. L. (1994) Isoforms of ferritin have a specific cellular distribution in the brain. J. Neurosci. Res. 37, 461–465.
    • (1994) J. Neurosci. Res. , vol.37 , pp. 461-465
    • Connor, J.R.1    Boeshore, K.L.2    Benkovic, S.A.3    Menzies, S.L.4
  • 63
    • 0029024235 scopus 로고
    • A histochemical study of iron-positive cells in the developing rat brain
    • Connor J. R., Pavlick G., Karli D., Menzies S. L. and Palmer C. (1995a) A histochemical study of iron-positive cells in the developing rat brain. J. Comp. Neurol. 355, 111–123.
    • (1995) J. Comp. Neurol. , vol.355 , pp. 111-123
    • Connor, J.R.1    Pavlick, G.2    Karli, D.3    Menzies, S.L.4    Palmer, C.5
  • 64
    • 0029092802 scopus 로고
    • A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains
    • Connor J. R., Snyder B. S., Arosio P., Loeffler D. A. and LeWitt P. (1995b) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65, 717–724.
    • (1995) J. Neurochem. , vol.65 , pp. 717-724
    • Connor, J.R.1    Snyder, B.S.2    Arosio, P.3    Loeffler, D.A.4    LeWitt, P.5
  • 66
    • 33747154110 scopus 로고    scopus 로고
    • Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder
    • Cozzi A., Santambrogio P., Corsi B., Campanella A., Arosio P. and Levi S. (2006) Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder. Neurobiol. Dis. 23, 644–652.
    • (2006) Neurobiol. Dis. , vol.23 , pp. 644-652
    • Cozzi, A.1    Santambrogio, P.2    Corsi, B.3    Campanella, A.4    Arosio, P.5    Levi, S.6
  • 68
    • 0026472376 scopus 로고
    • Iron metabolism–new perspectives in view
    • Crichton R. R. and Ward R. J. (1992) Iron metabolism–new perspectives in view. Biochemistry 31, 11255–11264.
    • (1992) Biochemistry , vol.31 , pp. 11255-11264
    • Crichton, R.R.1    Ward, R.J.2
  • 69
    • 80052684579 scopus 로고    scopus 로고
    • The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity
    • Crouch P. J., Savva M. S., Hung L. W. et al. (2011) The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity. J. Neurochem. 119, 220–230.
    • (2011) J. Neurochem. , vol.119 , pp. 220-230
    • Crouch, P.J.1    Savva, M.S.2    Hung, L.W.3
  • 70
    • 0026779690 scopus 로고
    • Iron and transferrin uptake by brain and cerebrospinal fluid in the rat
    • Crowe A. and Morgan E. H. (1992) Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res. 592, 8–16.
    • (1992) Brain Res. , vol.592 , pp. 8-16
    • Crowe, A.1    Morgan, E.H.2
  • 71
    • 80052689794 scopus 로고    scopus 로고
    • Hepcidin and ferroportin: the new players in iron metabolism
    • De Domenico I., Ward D. M. and Kaplan J. (2011) Hepcidin and ferroportin: the new players in iron metabolism. Semin. Liver Dis. 31, 272–279.
    • (2011) Semin. Liver Dis. , vol.31 , pp. 272-279
    • De Domenico, I.1    Ward, D.M.2    Kaplan, J.3
  • 72
    • 1042301280 scopus 로고    scopus 로고
    • Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain
    • Deane R., Zheng W. and Zlokovic B. V. (2004) Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. J. Neurochem. 88, 813–820.
    • (2004) J. Neurochem. , vol.88 , pp. 813-820
    • Deane, R.1    Zheng, W.2    Zlokovic, B.V.3
  • 73
    • 84856570373 scopus 로고    scopus 로고
    • Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons
    • Decressac M., Mattsson B., Lundblad M., Weikop P. and Bjorklund A. (2012) Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol. Dis. 45, 939–953.
    • (2012) Neurobiol. Dis. , vol.45 , pp. 939-953
    • Decressac, M.1    Mattsson, B.2    Lundblad, M.3    Weikop, P.4    Bjorklund, A.5
  • 74
    • 84897930725 scopus 로고    scopus 로고
    • Targeting chelatable iron as a therapeutic modality in Parkinson's disease
    • Devos D., Moreau C., Devedjian J. C. et al. (2014) Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid. Redox Signal. 21, 195–210.
    • (2014) Antioxid. Redox Signal. , vol.21 , pp. 195-210
    • Devos, D.1    Moreau, C.2    Devedjian, J.C.3
  • 76
    • 0024356620 scopus 로고
    • Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease
    • Dexter D. T., Wells F. R., Lees A. J., Agid F., Agid Y., Jenner P. and Marsden C. D. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830–1836.
    • (1989) J. Neurochem. , vol.52 , pp. 1830-1836
    • Dexter, D.T.1    Wells, F.R.2    Lees, A.J.3    Agid, F.4    Agid, Y.5    Jenner, P.6    Marsden, C.D.7
  • 77
    • 0025821265 scopus 로고
    • Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia
    • Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P. and Marsden C. D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4), 1953–1975.
    • (1991) Brain , vol.114 , pp. 1953-1975
    • Dexter, D.T.1    Carayon, A.2    Javoy-Agid, F.3    Agid, Y.4    Wells, F.R.5    Daniel, S.E.6    Lees, A.J.7    Jenner, P.8    Marsden, C.D.9
  • 78
    • 65249141710 scopus 로고    scopus 로고
    • Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease
    • Ding B., Chen K. M., Ling H. W. et al. (2009) Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J. Magn. Reson. Imaging 29, 793–798.
    • (2009) J. Magn. Reson. Imaging , vol.29 , pp. 793-798
    • Ding, B.1    Chen, K.M.2    Ling, H.W.3
  • 79
    • 84890922670 scopus 로고    scopus 로고
    • The role of iron and reactive oxygen species in cell death
    • Dixon S. J. and Stockwell B. R. (2014) The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9–17.
    • (2014) Nat. Chem. Biol. , vol.10 , pp. 9-17
    • Dixon, S.J.1    Stockwell, B.R.2
  • 80
    • 84861541814 scopus 로고    scopus 로고
    • Ferroptosis: an iron-dependent form of nonapoptotic cell death
    • Dixon S. J., Lemberg K. M., Lamprecht M. R. et al. (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072.
    • (2012) Cell , vol.149 , pp. 1060-1072
    • Dixon, S.J.1    Lemberg, K.M.2    Lamprecht, M.R.3
  • 83
    • 77956647381 scopus 로고    scopus 로고
    • Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
    • Duce J. A., Tsatsanis A., Cater M. A. et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857–867.
    • (2010) Cell , vol.142 , pp. 857-867
    • Duce, J.A.1    Tsatsanis, A.2    Cater, M.A.3
  • 84
    • 33749506795 scopus 로고    scopus 로고
    • Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
    • Engler H., Forsberg A., Almkvist O. et al. (2006) Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129, 2856–2866.
    • (2006) Brain , vol.129 , pp. 2856-2866
    • Engler, H.1    Forsberg, A.2    Almkvist, O.3
  • 85
    • 0028174370 scopus 로고
    • The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis
    • Enochs W. S., Sarna T., Zecca L., Riley P. A. and Swartz H. M. (1994) The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J. Neural. Transm. Park. Dis. Dement. Sect. 7, 83–100.
    • (1994) J. Neural. Transm. Park. Dis. Dement. Sect. , vol.7 , pp. 83-100
    • Enochs, W.S.1    Sarna, T.2    Zecca, L.3    Riley, P.A.4    Swartz, H.M.5
  • 86
    • 0027358656 scopus 로고
    • Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA
    • Fahmy M. and Young S. P. (1993) Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem. J. 296(Pt 1), 175–181.
    • (1993) Biochem. J. , vol.296 , pp. 175-181
    • Fahmy, M.1    Young, S.P.2
  • 87
    • 0036798434 scopus 로고    scopus 로고
    • Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
    • Faucheux B. A., Martin M. E., Beaumont C., Hunot S., Hauw J. J., Agid Y. and Hirsch E. C. (2002) Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J. Neurochem. 83, 320–330.
    • (2002) J. Neurochem. , vol.83 , pp. 320-330
    • Faucheux, B.A.1    Martin, M.E.2    Beaumont, C.3    Hunot, S.4    Hauw, J.J.5    Agid, Y.6    Hirsch, E.C.7
  • 88
    • 84908897414 scopus 로고    scopus 로고
    • An anemia of Alzheimer's disease
    • Faux N. G., Rembach A., Wiley J. et al. (2014) An anemia of Alzheimer's disease. Mol. Psychiatry 19, 1227–1234.
    • (2014) Mol. Psychiatry , vol.19 , pp. 1227-1234
    • Faux, N.G.1    Rembach, A.2    Wiley, J.3
  • 89
    • 0025954066 scopus 로고
    • Ageing and Parkinson's disease: substantia nigra regional selectivity
    • Fearnley J. M. and Lees A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114(Pt 5), 2283–2301.
    • (1991) Brain , vol.114 , pp. 2283-2301
    • Fearnley, J.M.1    Lees, A.J.2
  • 90
    • 84876976065 scopus 로고    scopus 로고
    • Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein rAAV Parkinson's model
    • Febbraro F., Andersen K. J., Sanchez-Guajardo V., Tentillier N. and Romero-Ramos M. (2013) Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein rAAV Parkinson's model. Exp. Neurol. 247, 45–58.
    • (2013) Exp. Neurol. , vol.247 , pp. 45-58
    • Febbraro, F.1    Andersen, K.J.2    Sanchez-Guajardo, V.3    Tentillier, N.4    Romero-Ramos, M.5
  • 91
    • 84874768493 scopus 로고    scopus 로고
    • Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice
    • Fine J. M., Baillargeon A. M., Renner D. B. et al. (2012) Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice. Exp. Brain Res. 219, 381–390.
    • (2012) Exp. Brain Res. , vol.219 , pp. 381-390
    • Fine, J.M.1    Baillargeon, A.M.2    Renner, D.B.3
  • 92
    • 84925286831 scopus 로고    scopus 로고
    • Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
    • Friedmann Angeli J. P., Schneider M., Proneth B. et al. (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180–1191.
    • (2014) Nat. Cell Biol. , vol.16 , pp. 1180-1191
    • Friedmann Angeli, J.P.1    Schneider, M.2    Proneth, B.3
  • 93
    • 84939986310 scopus 로고    scopus 로고
    • Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
    • Galluzzi L., Bravo-San Pedro J. M., Vitale I. et al. (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 22, 58–73.
    • (2015) Cell Death Differ. , vol.22 , pp. 58-73
    • Galluzzi, L.1    Bravo-San Pedro, J.M.2    Vitale, I.3
  • 94
    • 0028000825 scopus 로고
    • Altered brain metabolism of iron as a cause of neurodegenerative diseases?
    • Gerlach M., Ben-Shachar D., Riederer P. and Youdim M. B. (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63, 793–807.
    • (1994) J. Neurochem. , vol.63 , pp. 793-807
    • Gerlach, M.1    Ben-Shachar, D.2    Riederer, P.3    Youdim, M.B.4
  • 95
    • 84922814574 scopus 로고    scopus 로고
    • R2* mapping for brain iron: associations with cognition in normal aging
    • Ghadery C., Pirpamer L., Hofer E. et al. (2014) R2* mapping for brain iron: associations with cognition in normal aging. Neurobiol. Aging, 36, 925–932.
    • (2014) Neurobiol. Aging , vol.36 , pp. 925-932
    • Ghadery, C.1    Pirpamer, L.2    Hofer, E.3
  • 96
    • 50149099153 scopus 로고    scopus 로고
    • Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice
    • Ghosh M. C., Tong W. H., Zhang D., Ollivierre-Wilson H., Singh A., Krishna M. C., Mitchell J. B. and Rouault T. A. (2008) Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice. Proc. Natl Acad. Sci. USA 105, 12028–12033.
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , pp. 12028-12033
    • Ghosh, M.C.1    Tong, W.H.2    Zhang, D.3    Ollivierre-Wilson, H.4    Singh, A.5    Krishna, M.C.6    Mitchell, J.B.7    Rouault, T.A.8
  • 97
    • 84873338684 scopus 로고    scopus 로고
    • Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha
    • Ghosh M. C., Zhang D. L., Jeong S. Y. et al. (2013) Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha. Cell Metab. 17, 271–281.
    • (2013) Cell Metab. , vol.17 , pp. 271-281
    • Ghosh, M.C.1    Zhang, D.L.2    Jeong, S.Y.3
  • 98
    • 84938039523 scopus 로고
    • Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis
    • Goodman L. (1953) Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 118, 97–130.
    • (1953) J. Nerv. Ment. Dis. , vol.118 , pp. 97-130
    • Goodman, L.1
  • 99
    • 84875697145 scopus 로고    scopus 로고
    • Metal dyshomeostasis and oxidative stress in Alzheimer's disease
    • Greenough M. A., Camakaris J. and Bush A. I. (2013) Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem. Int. 62, 540–555.
    • (2013) Neurochem. Int. , vol.62 , pp. 540-555
    • Greenough, M.A.1    Camakaris, J.2    Bush, A.I.3
  • 100
    • 0027193251 scopus 로고
    • Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease
    • Griffiths P. D. and Crossman A. R. (1993) Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 4, 61–65.
    • (1993) Dementia , vol.4 , pp. 61-65
    • Griffiths, P.D.1    Crossman, A.R.2
  • 101
    • 0032898122 scopus 로고    scopus 로고
    • Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy
    • Griffiths P. D., Dobson B. R., Jones G. R. and Clarke D. T. (1999) Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain, 122 (Pt 4), 667–673.
    • (1999) Brain , vol.122 , pp. 667-673
    • Griffiths, P.D.1    Dobson, B.R.2    Jones, G.R.3    Clarke, D.T.4
  • 102
    • 67849106894 scopus 로고    scopus 로고
    • Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease
    • Grossi C., Francese S., Casini A. et al. (2009) Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 17, 423–440.
    • (2009) J. Alzheimers Dis. , vol.17 , pp. 423-440
    • Grossi, C.1    Francese, S.2    Casini, A.3
  • 103
    • 33747179546 scopus 로고    scopus 로고
    • Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort
    • Guerreiro R. J., Bras J. M., Santana I. et al. (2006) Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol. 6, 24.
    • (2006) BMC Neurol. , vol.6 , pp. 24
    • Guerreiro, R.J.1    Bras, J.M.2    Santana, I.3
  • 104
    • 84938261417 scopus 로고    scopus 로고
    • Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients
    • Guerreiro C., Silva B., Crespo A. C. et al. (2015) Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients. Biochim. Biophys. Acta, 1852, 2116–2122.
    • (2015) Biochim. Biophys. Acta , vol.1852 , pp. 2116-2122
    • Guerreiro, C.1    Silva, B.2    Crespo, A.C.3
  • 105
    • 84869080922 scopus 로고    scopus 로고
    • Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
    • Guo C., Wang T., Zheng W., Shan Z. Y., Teng W. P. and Wang Z. Y. (2013) Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 34, 562–575.
    • (2013) Neurobiol. Aging , vol.34 , pp. 562-575
    • Guo, C.1    Wang, T.2    Zheng, W.3    Shan, Z.Y.4    Teng, W.P.5    Wang, Z.Y.6
  • 106
    • 84936118142 scopus 로고    scopus 로고
    • Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1alpha pathway on the brain of APP/PS1 transgenic mice
    • Guo C., Zhang Y. X., Wang T., Zhong M. L., Yang Z. H., Hao L. J., Chai R. and Zhang S. (2015) Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1alpha pathway on the brain of APP/PS1 transgenic mice. Front. Aging Neurosci. 7, 104.
    • (2015) Front. Aging Neurosci. , vol.7 , pp. 104
    • Guo, C.1    Zhang, Y.X.2    Wang, T.3    Zhong, M.L.4    Yang, Z.H.5    Hao, L.J.6    Chai, R.7    Zhang, S.8
  • 107
    • 13944261999 scopus 로고    scopus 로고
    • Imaging iron stores in the brain using magnetic resonance imaging
    • Haacke E. M., Cheng N. Y., House M. J. et al. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 23, 1–25.
    • (2005) Magn. Reson. Imaging , vol.23 , pp. 1-25
    • Haacke, E.M.1    Cheng, N.Y.2    House, M.J.3
  • 108
    • 0037309720 scopus 로고    scopus 로고
    • Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats
    • Han J., Day J. R., Connor J. R. and Beard J. L. (2003) Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats. Nutr. Neurosci. 6, 1–10.
    • (2003) Nutr. Neurosci. , vol.6 , pp. 1-10
    • Han, J.1    Day, J.R.2    Connor, J.R.3    Beard, J.L.4
  • 109
    • 84897365963 scopus 로고    scopus 로고
    • A delicate balance: iron metabolism and diseases of the brain
    • Hare D., Ayton S., Bush A. and Lei P. (2013a) A delicate balance: iron metabolism and diseases of the brain. Front. Aging Neurosci. 5, 34.
    • (2013) Front. Aging Neurosci. , vol.5 , pp. 34
    • Hare, D.1    Ayton, S.2    Bush, A.3    Lei, P.4
  • 110
    • 84888192566 scopus 로고    scopus 로고
    • Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry
    • Hare D. J., Grubman A., Ryan T. M. et al. (2013b) Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry. Metallomics, 5, 1656–1662.
    • (2013) Metallomics , vol.5 , pp. 1656-1662
    • Hare, D.J.1    Grubman, A.2    Ryan, T.M.3
  • 111
    • 84900302515 scopus 로고    scopus 로고
    • An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta
    • Hare D. J., Lei P., Ayton S. et al. (2014) An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta. Chem. Sci. 5, 2160–2169.
    • (2014) Chem. Sci. , vol.5 , pp. 2160-2169
    • Hare, D.J.1    Lei, P.2    Ayton, S.3
  • 113
    • 84925682121 scopus 로고    scopus 로고
    • Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation
    • Hare D. J., Doecke J. D., Faux N. G. et al. (2015b) Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation. ACS Chem. Neurosci. 6, 398–402.
    • (2015) ACS Chem. Neurosci. , vol.6 , pp. 398-402
    • Hare, D.J.1    Doecke, J.D.2    Faux, N.G.3
  • 114
    • 0000819723 scopus 로고
    • Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution
    • Hill J. M., Ruff M. R., Weber R. J. and Pert C. B. (1985) Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc. Natl Acad. Sci. USA 82, 4553–4557.
    • (1985) Proc. Natl Acad. Sci. USA , vol.82 , pp. 4553-4557
    • Hill, J.M.1    Ruff, M.R.2    Weber, R.J.3    Pert, C.B.4
  • 115
    • 27244457379 scopus 로고    scopus 로고
    • DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression
    • Hintze K. J. and Theil E. C. (2005) DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc. Natl Acad. Sci. USA 102, 15048–15052.
    • (2005) Proc. Natl Acad. Sci. USA , vol.102 , pp. 15048-15052
    • Hintze, K.J.1    Theil, E.C.2
  • 116
    • 0026034279 scopus 로고
    • Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis
    • Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F. and Agid Y. (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56, 446–451.
    • (1991) J. Neurochem. , vol.56 , pp. 446-451
    • Hirsch, E.C.1    Brandel, J.P.2    Galle, P.3    Javoy-Agid, F.4    Agid, Y.5
  • 117
    • 84909578703 scopus 로고    scopus 로고
    • Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
    • Huang Y. and Mahley R. W. (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol. Dis., 72PA, 3–12.
    • (2014) Neurobiol. Dis. , vol.72PA , pp. 3-12
    • Huang, Y.1    Mahley, R.W.2
  • 118
    • 0033601338 scopus 로고    scopus 로고
    • Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction
    • Huang X., Cuajungco M. P., Atwood C. S. et al. (1999) Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274, 37111–37116.
    • (1999) J. Biol. Chem. , vol.274 , pp. 37111-37116
    • Huang, X.1    Cuajungco, M.P.2    Atwood, C.S.3
  • 119
    • 12144282992 scopus 로고    scopus 로고
    • Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides
    • Huang X., Atwood C. S., Moir R. D., Hartshorn M. A., Tanzi R. E. and Bush A. I. (2004) Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J. Biol. Inorg. Chem. 9, 954–960.
    • (2004) J. Biol. Inorg. Chem. , vol.9 , pp. 954-960
    • Huang, X.1    Atwood, C.S.2    Moir, R.D.3    Hartshorn, M.A.4    Tanzi, R.E.5    Bush, A.I.6
  • 121
    • 84926387317 scopus 로고    scopus 로고
    • Ferroptosis as a p53-mediated activity during tumour suppression
    • Jiang L., Kon N., Li T., Wang S. J., Su T., Hibshoosh H., Baer R. and Gu W. (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57–62.
    • (2015) Nature , vol.520 , pp. 57-62
    • Jiang, L.1    Kon, N.2    Li, T.3    Wang, S.J.4    Su, T.5    Hibshoosh, H.6    Baer, R.7    Gu, W.8
  • 122
    • 78449282609 scopus 로고    scopus 로고
    • Metals, oxidative stress and neurodegenerative disorders
    • Jomova K., Vondrakova D., Lawson M. and Valko M. (2010) Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 345, 91–104.
    • (2010) Mol. Cell. Biochem. , vol.345 , pp. 91-104
    • Jomova, K.1    Vondrakova, D.2    Lawson, M.3    Valko, M.4
  • 123
    • 0242684415 scopus 로고    scopus 로고
    • Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease
    • Kaur D., Yantiri F., Rajagopalan S. et al. (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37, 899–909.
    • (2003) Neuron , vol.37 , pp. 899-909
    • Kaur, D.1    Yantiri, F.2    Rajagopalan, S.3
  • 125
    • 85047682134 scopus 로고    scopus 로고
    • Steap proteins: implications for iron and copper metabolism
    • Knutson M. D. (2007) Steap proteins: implications for iron and copper metabolism. Nutr. Rev. 65, 335–340.
    • (2007) Nutr. Rev. , vol.65 , pp. 335-340
    • Knutson, M.D.1
  • 127
    • 79954460490 scopus 로고    scopus 로고
    • Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)
    • Kurian M. A., McNeill A., Lin J. P. and Maher E. R. (2011) Childhood disorders of neurodegeneration with brain iron accumulation (NBIA). Dev. Med. Child Neurol. 53, 394–404.
    • (2011) Dev. Med. Child Neurol. , vol.53 , pp. 394-404
    • Kurian, M.A.1    McNeill, A.2    Lin, J.P.3    Maher, E.R.4
  • 130
    • 0035138456 scopus 로고    scopus 로고
    • Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice
    • LaVaute T., Smith S., Cooperman S. et al. (2001) Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27, 209–214.
    • (2001) Nat. Genet. , vol.27 , pp. 209-214
    • LaVaute, T.1    Smith, S.2    Cooperman, S.3
  • 132
    • 84856708923 scopus 로고    scopus 로고
    • Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
    • Lei P., Ayton S., Finkelstein D. I. et al. (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291–295.
    • (2012) Nat. Med. , vol.18 , pp. 291-295
    • Lei, P.1    Ayton, S.2    Finkelstein, D.I.3
  • 135
    • 84906417439 scopus 로고
    • Original papers: on the occurrence of abnormal deposits of iron in the brain in parkinsonism with special reference to its localisation
    • Lhermitte J., Kraus W. M. and McAlpine D. (1924) Original papers: on the occurrence of abnormal deposits of iron in the brain in parkinsonism with special reference to its localisation. J. Neurol. Psychopathol. 5, 195–208.
    • (1924) J. Neurol. Psychopathol. , vol.5 , pp. 195-208
    • Lhermitte, J.1    Kraus, W.M.2    McAlpine, D.3
  • 136
    • 77649268711 scopus 로고    scopus 로고
    • Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
    • Li L., Fang C. J., Ryan J. C. et al. (2010) Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc. Natl Acad. Sci. USA 107, 3505–3510.
    • (2010) Proc. Natl Acad. Sci. USA , vol.107 , pp. 3505-3510
    • Li, L.1    Fang, C.J.2    Ryan, J.C.3
  • 137
    • 79952996094 scopus 로고    scopus 로고
    • Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation
    • Liu B., Moloney A., Meehan S. et al. (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J. Biol. Chem. 286, 4248–4256.
    • (2011) J. Biol. Chem. , vol.286 , pp. 4248-4256
    • Liu, B.1    Moloney, A.2    Meehan, S.3
  • 139
    • 0036884733 scopus 로고    scopus 로고
    • Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein
    • Lotharius J. and Brundin P. (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3, 932–942.
    • (2002) Nat. Rev. Neurosci. , vol.3 , pp. 932-942
    • Lotharius, J.1    Brundin, P.2
  • 141
    • 12844250694 scopus 로고    scopus 로고
    • Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3
    • discussion 673-681
    • Lovell M. A., Xiong S., Xie C., Davies P. and Markesbery W. R. (2004) Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J. Alzheimers Dis., 6, 659–671; discussion 673-681.
    • (2004) J. Alzheimers Dis. , vol.6 , pp. 659-671
    • Lovell, M.A.1    Xiong, S.2    Xie, C.3    Davies, P.4    Markesbery, W.R.5
  • 142
    • 84937806176 scopus 로고    scopus 로고
    • Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the disruption of neuronal iron metabolism
    • Lu Q., Harris V. A., Rafikov R., Sun X., Kumar S. and Black S. M. (2015) Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the disruption of neuronal iron metabolism. Redox. Biol. 6, 112–121.
    • (2015) Redox. Biol. , vol.6 , pp. 112-121
    • Lu, Q.1    Harris, V.A.2    Rafikov, R.3    Sun, X.4    Kumar, S.5    Black, S.M.6
  • 143
    • 84884777832 scopus 로고    scopus 로고
    • The correlation of hippocampal T-mapping with neuropsychology test in patients with Alzheimer's disease
    • Luo Z., Zhuang X., Kumar D., Wu X., Yue C., Han C. and Lv J. (2013) The correlation of hippocampal T-mapping with neuropsychology test in patients with Alzheimer's disease. PLoS ONE 8, e76203.
    • (2013) PLoS ONE , vol.8
    • Luo, Z.1    Zhuang, X.2    Kumar, D.3    Wu, X.4    Yue, C.5    Han, C.6    Lv, J.7
  • 145
    • 0027327488 scopus 로고
    • Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide
    • Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R. and Maggio J. E. (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 61, 1171–1174.
    • (1993) J. Neurochem. , vol.61 , pp. 1171-1174
    • Mantyh, P.W.1    Ghilardi, J.R.2    Rogers, S.3    DeMaster, E.4    Allen, C.J.5    Stimson, E.R.6    Maggio, J.E.7
  • 146
    • 84879053438 scopus 로고    scopus 로고
    • Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux
    • McCarthy R. C. and Kosman D. J. (2013) Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux. J. Biol. Chem. 288, 17932–17940.
    • (2013) J. Biol. Chem. , vol.288 , pp. 17932-17940
    • McCarthy, R.C.1    Kosman, D.J.2
  • 147
    • 84903720548 scopus 로고    scopus 로고
    • sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin
    • McCarthy R. C., Park Y. H. and Kosman D. J. (2014) sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep. 15, 809–815.
    • (2014) EMBO Rep. , vol.15 , pp. 809-815
    • McCarthy, R.C.1    Park, Y.H.2    Kosman, D.J.3
  • 148
    • 65449184945 scopus 로고    scopus 로고
    • Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005
    • McLean E., Cogswell M., Egli I., Wojdyla D. and de Benoist B. (2009) Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 12, 444–454.
    • (2009) Public Health Nutr. , vol.12 , pp. 444-454
    • McLean, E.1    Cogswell, M.2    Egli, I.3    Wojdyla, D.4    de Benoist, B.5
  • 149
    • 10744223491 scopus 로고    scopus 로고
    • Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis
    • Meyron-Holtz E. G., Ghosh M. C., Iwai K. et al. (2004) Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 23, 386–395.
    • (2004) EMBO J. , vol.23 , pp. 386-395
    • Meyron-Holtz, E.G.1    Ghosh, M.C.2    Iwai, K.3
  • 152
    • 0347993815 scopus 로고    scopus 로고
    • The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain
    • Moos T. and Morgan E. H. (2004) The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J. Neurochem. 88, 233–245.
    • (2004) J. Neurochem. , vol.88 , pp. 233-245
    • Moos, T.1    Morgan, E.H.2
  • 153
    • 33748090285 scopus 로고    scopus 로고
    • Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1
    • Moos T., Skjoerringe T., Gosk S. and Morgan E. H. (2006) Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J. Neurochem. 98, 1946–1958.
    • (2006) J. Neurochem. , vol.98 , pp. 1946-1958
    • Moos, T.1    Skjoerringe, T.2    Gosk, S.3    Morgan, E.H.4
  • 155
    • 84922479199 scopus 로고    scopus 로고
    • Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease
    • Morris G. P., Clark I. A. and Vissel B. (2014) Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta. Neuropathol. Commun. 2, 135.
    • (2014) Acta. Neuropathol. Commun. , vol.2 , pp. 135
    • Morris, G.P.1    Clark, I.A.2    Vissel, B.3
  • 156
    • 50949102412 scopus 로고    scopus 로고
    • Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network
    • Muckenthaler M. U., Galy B. and Hentze M. W. (2008) Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28, 197–213.
    • (2008) Annu. Rev. Nutr. , vol.28 , pp. 197-213
    • Muckenthaler, M.U.1    Galy, B.2    Hentze, M.W.3
  • 157
    • 79951671438 scopus 로고    scopus 로고
    • Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration
    • Muhoberac B. B., Baraibar M. A. and Vidal R. (2011) Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration. Biochim. Biophys. Acta 1812, 544–548.
    • (2011) Biochim. Biophys. Acta , vol.1812 , pp. 544-548
    • Muhoberac, B.B.1    Baraibar, M.A.2    Vidal, R.3
  • 158
    • 79955492902 scopus 로고    scopus 로고
    • HFE gene variants affect iron in the brain
    • Nandar W. and Connor J. R. (2011) HFE gene variants affect iron in the brain. J. Nutr. 141, 729S–739S.
    • (2011) J. Nutr. , vol.141 , pp. 729S-739S
    • Nandar, W.1    Connor, J.R.2
  • 159
    • 77954104112 scopus 로고    scopus 로고
    • Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
    • Nuytemans K., Theuns J., Cruts M. and Van Broeckhoven C. (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum. Mutat. 31, 763–780.
    • (2010) Hum. Mutat. , vol.31 , pp. 763-780
    • Nuytemans, K.1    Theuns, J.2    Cruts, M.3    Van Broeckhoven, C.4
  • 160
    • 83455177604 scopus 로고    scopus 로고
    • Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention
    • Olivieri S., Conti A., Iannaccone S. et al. (2011) Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. J. Neurosci. 31, 18568–18577.
    • (2011) J. Neurosci. , vol.31 , pp. 18568-18577
    • Olivieri, S.1    Conti, A.2    Iannaccone, S.3
  • 161
    • 4444273210 scopus 로고    scopus 로고
    • Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models
    • Ortiz E., Pasquini J. M., Thompson K., Felt B., Butkus G., Beard J. and Connor J. R. (2004) Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J. Neurosci. Res. 77, 681–689.
    • (2004) J. Neurosci. Res. , vol.77 , pp. 681-689
    • Ortiz, E.1    Pasquini, J.M.2    Thompson, K.3    Felt, B.4    Butkus, G.5    Beard, J.6    Connor, J.R.7
  • 162
    • 0036703490 scopus 로고    scopus 로고
    • Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury
    • Patel B. N., Dunn R. J., Jeong S. Y., Zhu Q., Julien J. P. and David S. (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578–6586.
    • (2002) J. Neurosci. , vol.22 , pp. 6578-6586
    • Patel, B.N.1    Dunn, R.J.2    Jeong, S.Y.3    Zhu, Q.4    Julien, J.P.5    David, S.6
  • 163
    • 47849117346 scopus 로고    scopus 로고
    • Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population
    • Percy M., Moalem S., Garcia A. et al. (2008) Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population. J. Alzheimers Dis. 14, 69–84.
    • (2008) J. Alzheimers Dis. , vol.14 , pp. 69-84
    • Percy, M.1    Moalem, S.2    Garcia, A.3
  • 164
    • 9644270708 scopus 로고    scopus 로고
    • Dementia-free centenarians
    • Perls T. (2004) Dementia-free centenarians. Exp. Gerontol. 39, 1587–1593.
    • (2004) Exp. Gerontol. , vol.39 , pp. 1587-1593
    • Perls, T.1
  • 165
    • 18744374615 scopus 로고    scopus 로고
    • Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?
    • Perry G., Nunomura A., Hirai K. et al. (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. 33, 1475–1479.
    • (2002) Free Radic. Biol. Med. , vol.33 , pp. 1475-1479
    • Perry, G.1    Nunomura, A.2    Hirai, K.3
  • 166
    • 67349165691 scopus 로고    scopus 로고
    • MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods
    • Pfefferbaum A., Adalsteinsson E., Rohlfing T. and Sullivan E. V. (2009) MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. NeuroImage 47, 493–500.
    • (2009) NeuroImage , vol.47 , pp. 493-500
    • Pfefferbaum, A.1    Adalsteinsson, E.2    Rohlfing, T.3    Sullivan, E.V.4
  • 167
    • 84879529900 scopus 로고    scopus 로고
    • Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study
    • Pichler I., Del Greco M. F., Gogele M. et al. (2013) Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med. 10, e1001462.
    • (2013) PLoS Med. , vol.10
    • Pichler, I.1    Del Greco, M.F.2    Gogele, M.3
  • 168
    • 0037462675 scopus 로고    scopus 로고
    • Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones
    • Pietsch E. C., Chan J. Y., Torti F. M. and Torti S. V. (2003) Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J. Biol. Chem. 278, 2361–2369.
    • (2003) J. Biol. Chem. , vol.278 , pp. 2361-2369
    • Pietsch, E.C.1    Chan, J.Y.2    Torti, F.M.3    Torti, S.V.4
  • 169
    • 0030744876 scopus 로고    scopus 로고
    • Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
    • Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047.
    • (1997) Science , vol.276 , pp. 2045-2047
    • Polymeropoulos, M.H.1    Lavedan, C.2    Leroy, E.3
  • 170
    • 33747834381 scopus 로고    scopus 로고
    • p53-mediated apoptosis, neuroglobin overexpression, and globin deposits in a patient with hereditary ferritinopathy
    • Powers J. M. (2006) p53-mediated apoptosis, neuroglobin overexpression, and globin deposits in a patient with hereditary ferritinopathy. J. Neuropathol. Exp. Neurol. 65, 716–721.
    • (2006) J. Neuropathol. Exp. Neurol. , vol.65 , pp. 716-721
    • Powers, J.M.1
  • 171
    • 67349184808 scopus 로고    scopus 로고
    • Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
    • Price J. L., McKeel D. W. Jr, Buckles V. D. et al. (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging 30, 1026–1036.
    • (2009) Neurobiol. Aging , vol.30 , pp. 1026-1036
    • Price, J.L.1    McKeel, D.W.2    Buckles, V.D.3
  • 172
    • 0029984860 scopus 로고    scopus 로고
    • Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
    • Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L. and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 4565–4571.
    • (1996) Proc. Natl Acad. Sci. USA , vol.93 , pp. 4565-4571
    • Przedborski, S.1    Jackson-Lewis, V.2    Yokoyama, R.3    Shibata, T.4    Dawson, V.L.5    Dawson, T.M.6
  • 174
    • 84930077320 scopus 로고    scopus 로고
    • High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry
    • Pyatigorskaya N., Sharman M., Corvol J. C. et al. (2015) High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry. Mov. Disord. 30, 1077–1084.
    • (2015) Mov. Disord. , vol.30 , pp. 1077-1084
    • Pyatigorskaya, N.1    Sharman, M.2    Corvol, J.C.3
  • 175
    • 0029029016 scopus 로고
    • Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes
    • Qi Y., Jamindar T. M. and Dawson G. (1995) Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J. Neurochem. 64, 2458–2464.
    • (1995) J. Neurochem. , vol.64 , pp. 2458-2464
    • Qi, Y.1    Jamindar, T.M.2    Dawson, G.3
  • 176
    • 80455155223 scopus 로고    scopus 로고
    • Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2’ mapping
    • Qin Y., Zhu W., Zhan C., Zhao L., Wang J., Tian Q. and Wang W. (2011) Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2’ mapping. J. Huazhong Univ. Sci. Technolog Med. Sci. 31, 578–585.
    • (2011) J. Huazhong Univ. Sci. Technolog Med. Sci. , vol.31 , pp. 578-585
    • Qin, Y.1    Zhu, W.2    Zhan, C.3    Zhao, L.4    Wang, J.5    Tian, Q.6    Wang, W.7
  • 177
    • 84884696816 scopus 로고    scopus 로고
    • Perinatal iron deficiency and neurocognitive development
    • Radlowski E. C. and Johnson R. W. (2013) Perinatal iron deficiency and neurocognitive development. Front. Hum. Neurosci. 7, 585.
    • (2013) Front. Hum. Neurosci. , vol.7 , pp. 585
    • Radlowski, E.C.1    Johnson, R.W.2
  • 178
    • 84874284249 scopus 로고    scopus 로고
    • Systemic and cellular consequences of macrophage control of iron metabolism
    • Recalcati S., Locati M. and Cairo G. (2012) Systemic and cellular consequences of macrophage control of iron metabolism. Semin. Immunol. 24, 393–398.
    • (2012) Semin. Immunol. , vol.24 , pp. 393-398
    • Recalcati, S.1    Locati, M.2    Cairo, G.3
  • 180
    • 10744224267 scopus 로고    scopus 로고
    • Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial
    • Ritchie C. W., Bush A. I., Mackinnon A. et al. (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60, 1685–1691.
    • (2003) Arch. Neurol. , vol.60 , pp. 1685-1691
    • Ritchie, C.W.1    Bush, A.I.2    Mackinnon, A.3
  • 181
    • 78649663704 scopus 로고    scopus 로고
    • Differential effects of age and history of hypertension on regional brain volumes and iron
    • Rodrigue K. M., Haacke E. M. and Raz N. (2011) Differential effects of age and history of hypertension on regional brain volumes and iron. NeuroImage 54, 750–759.
    • (2011) NeuroImage , vol.54 , pp. 750-759
    • Rodrigue, K.M.1    Haacke, E.M.2    Raz, N.3
  • 182
    • 0033525735 scopus 로고    scopus 로고
    • Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5’-untranslated region sequences
    • Rogers J. T., Leiter L. M., McPhee J., Cahill C. M., Zhan S. S., Potter H. and Nilsson L. N. (1999) Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5’-untranslated region sequences. J. Biol. Chem. 274, 6421–6431.
    • (1999) J. Biol. Chem. , vol.274 , pp. 6421-6431
    • Rogers, J.T.1    Leiter, L.M.2    McPhee, J.3    Cahill, C.M.4    Zhan, S.S.5    Potter, H.6    Nilsson, L.N.7
  • 183
    • 0347928847 scopus 로고    scopus 로고
    • An iron-responsive element type II in the 5’-untranslated region of the Alzheimer's amyloid precursor protein transcript
    • Rogers J. T., Randall J. D., Cahill C. M. et al. (2002) An iron-responsive element type II in the 5’-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277, 45518–45528.
    • (2002) J. Biol. Chem. , vol.277 , pp. 45518-45528
    • Rogers, J.T.1    Randall, J.D.2    Cahill, C.M.3
  • 184
    • 0030005627 scopus 로고    scopus 로고
    • Apolipoprotein E alleles as risk factors in Alzheimer's disease
    • Roses A. D. (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 47, 387–400.
    • (1996) Annu. Rev. Med. , vol.47 , pp. 387-400
    • Roses, A.D.1
  • 185
    • 74449085808 scopus 로고    scopus 로고
    • Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins
    • Rouault T. A., Zhang D. L. and Jeong S. Y. (2009) Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab. Brain Dis. 24, 673–684.
    • (2009) Metab. Brain Dis. , vol.24 , pp. 673-684
    • Rouault, T.A.1    Zhang, D.L.2    Jeong, S.Y.3
  • 186
    • 84890115517 scopus 로고    scopus 로고
    • Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription
    • Ryan S. D., Dolatabadi N., Chan S. F. et al. (2013) Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351–1364.
    • (2013) Cell , vol.155 , pp. 1351-1364
    • Ryan, S.D.1    Dolatabadi, N.2    Chan, S.F.3
  • 187
    • 57449092273 scopus 로고    scopus 로고
    • Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
    • Salazar J., Mena N., Hunot S. et al. (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 18578–18583.
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , pp. 18578-18583
    • Salazar, J.1    Mena, N.2    Hunot, S.3
  • 189
    • 0029981111 scopus 로고    scopus 로고
    • Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes
    • Sanyal B., Polak P. E. and Szuchet S. (1996) Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes. J. Neurosci. Res. 46, 187–197.
    • (1996) J. Neurosci. Res. , vol.46 , pp. 187-197
    • Sanyal, B.1    Polak, P.E.2    Szuchet, S.3
  • 190
    • 0027327267 scopus 로고
    • Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
    • Saunders A. M., Strittmatter W. J., Schmechel D. et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467–1472.
    • (1993) Neurology , vol.43 , pp. 1467-1472
    • Saunders, A.M.1    Strittmatter, W.J.2    Schmechel, D.3
  • 192
    • 84875722419 scopus 로고    scopus 로고
    • Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA)
    • Schneider S. A. and Bhatia K. P. (2013) Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). J. Neural. Transm. 120, 695–703.
    • (2013) J. Neural. Transm. , vol.120 , pp. 695-703
    • Schneider, S.A.1    Bhatia, K.P.2
  • 194
    • 54049133647 scopus 로고    scopus 로고
    • A potential pathogenetic role of iron in Alzheimer's disease
    • Silvestri L. and Camaschella C. (2008) A potential pathogenetic role of iron in Alzheimer's disease. J. Cell Mol. Med. 12, 1548–1550.
    • (2008) J. Cell Mol. Med. , vol.12 , pp. 1548-1550
    • Silvestri, L.1    Camaschella, C.2
  • 195
    • 38349194098 scopus 로고    scopus 로고
    • Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
    • Silvestri L., Pagani A. and Camaschella C. (2008) Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111, 924–931.
    • (2008) Blood , vol.111 , pp. 924-931
    • Silvestri, L.1    Pagani, A.2    Camaschella, C.3
  • 197
    • 84894475785 scopus 로고    scopus 로고
    • Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities
    • Singh N., Haldar S., Tripathi A. K. et al. (2014) Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid. Redox Signal. 20, 1324–1363.
    • (2014) Antioxid. Redox Signal. , vol.20 , pp. 1324-1363
    • Singh, N.1    Haldar, S.2    Tripathi, A.K.3
  • 198
    • 0030885482 scopus 로고    scopus 로고
    • Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
    • Smith M. A., Harris P. L., Sayre L. M. and Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 94, 9866–9868.
    • (1997) Proc. Natl Acad. Sci. USA , vol.94 , pp. 9866-9868
    • Smith, M.A.1    Harris, P.L.2    Sayre, L.M.3    Perry, G.4
  • 200
    • 75149152568 scopus 로고    scopus 로고
    • Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment
    • Smith M. A., Zhu X., Tabaton M. et al. (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 19, 363–372.
    • (2010) J. Alzheimers Dis. , vol.19 , pp. 363-372
    • Smith, M.A.1    Zhu, X.2    Tabaton, M.3
  • 201
    • 67349112729 scopus 로고    scopus 로고
    • Iron, the substantia nigra and related neurological disorders
    • Snyder A. M. and Connor J. R. (2009) Iron, the substantia nigra and related neurological disorders. Biochim. Biophys. Acta 1790, 606–614.
    • (2009) Biochim. Biophys. Acta , vol.1790 , pp. 606-614
    • Snyder, A.M.1    Connor, J.R.2
  • 203
    • 0025963530 scopus 로고
    • Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
    • Sofic E., Paulus W., Jellinger K., Riederer P. and Youdim M. B. (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56, 978–982.
    • (1991) J. Neurochem. , vol.56 , pp. 978-982
    • Sofic, E.1    Paulus, W.2    Jellinger, K.3    Riederer, P.4    Youdim, M.B.5
  • 204
    • 0026794561 scopus 로고
    • Iron uptake in relation to transferrin degradation in brain and other tissues of rats
    • Strahan M. E., Crowe A. and Morgan E. H. (1992) Iron uptake in relation to transferrin degradation in brain and other tissues of rats. Am. J. Physiol. 263, R924–R929.
    • (1992) Am. J. Physiol. , vol.263 , pp. R924-R929
    • Strahan, M.E.1    Crowe, A.2    Morgan, E.H.3
  • 205
    • 84916882462 scopus 로고    scopus 로고
    • Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis
    • Tao Y., Wang Y., Rogers J. T. and Wang F. (2014) Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis. J. Alzheimers Dis. 42, 679–690.
    • (2014) J. Alzheimers Dis. , vol.42 , pp. 679-690
    • Tao, Y.1    Wang, Y.2    Rogers, J.T.3    Wang, F.4
  • 207
    • 79954616688 scopus 로고    scopus 로고
    • H-ferritin is the major source of iron for oligodendrocytes
    • Todorich B., Zhang X. and Connor J. R. (2011) H-ferritin is the major source of iron for oligodendrocytes. Glia 59, 927–935.
    • (2011) Glia , vol.59 , pp. 927-935
    • Todorich, B.1    Zhang, X.2    Connor, J.R.3
  • 208
    • 0035941201 scopus 로고    scopus 로고
    • Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure
    • Uversky V. N., Li J. and Fink A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276, 44284–44296.
    • (2001) J. Biol. Chem. , vol.276 , pp. 44284-44296
    • Uversky, V.N.1    Li, J.2    Fink, A.L.3
  • 209
    • 2442668926 scopus 로고    scopus 로고
    • Hereditary early-onset Parkinson's disease caused by mutations in PINK1
    • Valente E. M., Abou-Sleiman P. M., Caputo V. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–1160.
    • (2004) Science , vol.304 , pp. 1158-1160
    • Valente, E.M.1    Abou-Sleiman, P.M.2    Caputo, V.3
  • 210
    • 84862845774 scopus 로고    scopus 로고
    • Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells
    • Wan L., Nie G., Zhang J. and Zhao B. (2012) Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells. J. Alzheimers Dis. 30, 523–530.
    • (2012) J. Alzheimers Dis. , vol.30 , pp. 523-530
    • Wan, L.1    Nie, G.2    Zhang, J.3    Zhao, B.4
  • 211
    • 79952162002 scopus 로고    scopus 로고
    • Regulation of cellular iron metabolism
    • Wang J. and Pantopoulos K. (2011) Regulation of cellular iron metabolism. Biochem. J. 434, 365–381.
    • (2011) Biochem. J. , vol.434 , pp. 365-381
    • Wang, J.1    Pantopoulos, K.2
  • 212
    • 84911913522 scopus 로고    scopus 로고
    • Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice
    • Wang D., Hui Y., Peng Y. et al. (2015) Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice. J. Alzheimers Dis. 43, 519–534.
    • (2015) J. Alzheimers Dis. , vol.43 , pp. 519-534
    • Wang, D.1    Hui, Y.2    Peng, Y.3
  • 213
    • 84907999177 scopus 로고    scopus 로고
    • The role of iron in brain ageing and neurodegenerative disorders
    • Ward R. J., Zucca F. A., Duyn J. H., Crichton R. R. and Zecca L. (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 13, 1045–1060.
    • (2014) Lancet Neurol. , vol.13 , pp. 1045-1060
    • Ward, R.J.1    Zucca, F.A.2    Duyn, J.H.3    Crichton, R.R.4    Zecca, L.5
  • 215
    • 84884901205 scopus 로고    scopus 로고
    • Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
    • Weinreb O., Mandel S., Youdim M. B. and Amit T. (2013) Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators. Free Radic. Biol. Med. 62, 52–64.
    • (2013) Free Radic. Biol. Med. , vol.62 , pp. 52-64
    • Weinreb, O.1    Mandel, S.2    Youdim, M.B.3    Amit, T.4
  • 216
    • 77955600573 scopus 로고    scopus 로고
    • Iron homeostasis and the inflammatory response
    • Wessling-Resnick M. (2010) Iron homeostasis and the inflammatory response. Annu. Rev. Nutr. 30, 105–122.
    • (2010) Annu. Rev. Nutr. , vol.30 , pp. 105-122
    • Wessling-Resnick, M.1
  • 217
    • 58149084932 scopus 로고    scopus 로고
    • Chemistry and antihypertensive effects of tempol and other nitroxides
    • Wilcox C. S. and Pearlman A. (2008) Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol. Rev. 60, 418–469.
    • (2008) Pharmacol. Rev. , vol.60 , pp. 418-469
    • Wilcox, C.S.1    Pearlman, A.2
  • 218
    • 84902096220 scopus 로고    scopus 로고
    • The molecular biology of human iron metabolism
    • Winter W. E., Bazydlo L. A. and Harris N. S. (2014) The molecular biology of human iron metabolism. Lab. Med. 45, 92–102.
    • (2014) Lab. Med. , vol.45 , pp. 92-102
    • Winter, W.E.1    Bazydlo, L.A.2    Harris, N.S.3
  • 219
    • 84901058201 scopus 로고    scopus 로고
    • The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
    • Wong B. X. and Duce J. A. (2014) The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders. Fron. Pharmacol. 5, 81.
    • (2014) Fron. Pharmacol. , vol.5 , pp. 81
    • Wong, B.X.1    Duce, J.A.2
  • 220
    • 84907148276 scopus 로고    scopus 로고
    • A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe(2 +) under physiologically relevant conditions
    • Wong B. X., Ayton S., Lam L. Q., Lei P., Adlard P. A., Bush A. I. and Duce J. A. (2014a) A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe(2 +) under physiologically relevant conditions. Biochim. Biophys. Acta 1840, 3299–3310.
    • (2014) Biochim. Biophys. Acta , vol.1840 , pp. 3299-3310
    • Wong, B.X.1    Ayton, S.2    Lam, L.Q.3    Lei, P.4    Adlard, P.A.5    Bush, A.I.6    Duce, J.A.7
  • 221
    • 84914693430 scopus 로고    scopus 로고
    • beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin
    • Wong B. X., Tsatsanis A., Lim L. Q., Adlard P. A., Bush A. I. and Duce J. A. (2014b) beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS ONE 9, e114174.
    • (2014) PLoS ONE , vol.9
    • Wong, B.X.1    Tsatsanis, A.2    Lim, L.Q.3    Adlard, P.A.4    Bush, A.I.5    Duce, J.A.6
  • 222
    • 10744219518 scopus 로고    scopus 로고
    • Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier
    • Wu L. J., Leenders A. G., Cooperman S. et al. (2004) Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res. 1001, 108–117.
    • (2004) Brain Res. , vol.1001 , pp. 108-117
    • Wu, L.J.1    Leenders, A.G.2    Cooperman, S.3
  • 223
    • 33646911081 scopus 로고    scopus 로고
    • Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus
    • Xu Q., Bernardo A., Walker D., Kanegawa T., Mahley R. W. and Huang Y. (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26, 4985–4994.
    • (2006) J. Neurosci. , vol.26 , pp. 4985-4994
    • Xu, Q.1    Bernardo, A.2    Walker, D.3    Kanegawa, T.4    Mahley, R.W.5    Huang, Y.6
  • 224
    • 0036724204 scopus 로고    scopus 로고
    • Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease
    • Yamamoto A., Shin R. W., Hasegawa K., Naiki H., Sato H., Yoshimasu F. and Kitamoto T. (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J. Neurochem. 82, 1137–1147.
    • (2002) J. Neurochem. , vol.82 , pp. 1137-1147
    • Yamamoto, A.1    Shin, R.W.2    Hasegawa, K.3    Naiki, H.4    Sato, H.5    Yoshimasu, F.6    Kitamoto, T.7
  • 225
    • 0028006428 scopus 로고
    • Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain
    • Zecca L., Pietra R., Goj C., Mecacci C., Radice D. and Sabbioni E. (1994) Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J. Neurochem. 62, 1097–1101.
    • (1994) J. Neurochem. , vol.62 , pp. 1097-1101
    • Zecca, L.1    Pietra, R.2    Goj, C.3    Mecacci, C.4    Radice, D.5    Sabbioni, E.6
  • 226
    • 0035103932 scopus 로고    scopus 로고
    • Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
    • Zecca L., Gallorini M., Schunemann V., Trautwein A. X., Gerlach M., Riederer P., Vezzoni P. and Tampellini D. (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J. Neurochem. 76, 1766–1773.
    • (2001) J. Neurochem. , vol.76 , pp. 1766-1773
    • Zecca, L.1    Gallorini, M.2    Schunemann, V.3    Trautwein, A.X.4    Gerlach, M.5    Riederer, P.6    Vezzoni, P.7    Tampellini, D.8
  • 227
    • 3042793602 scopus 로고    scopus 로고
    • The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
    • Zecca L., Stroppolo A., Gatti A. et al. (2004a) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl Acad. Sci. USA 101, 9843–9848.
    • (2004) Proc. Natl Acad. Sci. USA , vol.101 , pp. 9843-9848
    • Zecca, L.1    Stroppolo, A.2    Gatti, A.3
  • 229
    • 33750535445 scopus 로고    scopus 로고
    • Cellular iron status influences the functional relationship between microglia and oligodendrocytes
    • Zhang X., Surguladze N., Slagle-Webb B., Cozzi A. and Connor J. R. (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54, 795–804.
    • (2006) Glia , vol.54 , pp. 795-804
    • Zhang, X.1    Surguladze, N.2    Slagle-Webb, B.3    Cozzi, A.4    Connor, J.R.5
  • 230
    • 84904738032 scopus 로고    scopus 로고
    • The physiological functions of iron regulatory proteins in iron homeostasis - an update
    • Zhang D. L., Ghosh M. C. and Rouault T. A. (2014) The physiological functions of iron regulatory proteins in iron homeostasis - an update. Front. Pharmacol. 5, 124.
    • (2014) Front. Pharmacol. , vol.5 , pp. 124
    • Zhang, D.L.1    Ghosh, M.C.2    Rouault, T.A.3
  • 231
    • 77950118979 scopus 로고    scopus 로고
    • Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease
    • Zhu W. Z., Zhong W. D., Wang W., Zhan C. J., Wang C. Y., Qi J. P., Wang J. Z. and Lei T. (2009) Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 253, 497–504.
    • (2009) Radiology , vol.253 , pp. 497-504
    • Zhu, W.Z.1    Zhong, W.D.2    Wang, W.3    Zhan, C.J.4    Wang, C.Y.5    Qi, J.P.6    Wang, J.Z.7    Lei, T.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.